The company plans to launch 14 products in Brazil, targeting a potential market of USD 2 billion, expanding access to high-complexity treatments in key therapeutic areas, expecting to generate over USD 130 million in sales within the next 4 years. Through strategic...
CStone will receive upfront, regulatory and commercial milestone payments, and book revenue from SteinCares through the supply of sugemalimab in 10 Latin American (LATAM) countries. This marks CStone’s third major global commercialization partnership for...
SteinCares has strengthened its product portfolio in Colombia through an expanded agreement with Pharmacosmos for the commercialization and distribution of Monofer®, an innovative intravenous iron replacement therapy. This alliance reinforces SteinCares’...
Strategic partnership in Latin America extended to cover five additional products in therapeutic categories including oncology, pulmonary hypertension, and rare diseases. The current market size of the products included in the agreement exceeds USD 100 million. Adalvo...
IFC’s direct equity investment will accelerate SteinCares’ geographical growth and strengthen its portfolio of innovative and biosimilar medicines. San Jose, Costa Rica, May 29, 2023—The International Finance Corporation (IFC), a member of the World Bank Group,...
